Mark R Thursz (Mark Thursz)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Topics

Clostridium Difficile

Systematic Review

Top Venues

Alimentary pharmacology & therapeutics

International journal of molecular sciences

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

Nila Jambulingam, Roberta Forlano, Benjamin Preston, Benjamin Harvey Mullish, Greta Portone, Yama Baheer, Michael Yee, Robert D Goldin, Mark R Thursz, Pinelopi Manousou
Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. International journal of molecular sciences 24 (4) (2023)
Nila Jambulingam, Roberta Forlano, Benjamin Preston, Benjamin Harvey Mullish, Greta Portone, Yama Baheer, Michael Yee, Robert D Goldin, Mark R Thursz, Pinelopi Manousou
Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. International journal of molecular sciences 24 (4) (2023)
Nila Jambulingam, Roberta Forlano, Benjamin Preston, Benjamin Harvey Mullish, Greta Portone, Yama Baheer, Michael Yee, Robert D Goldin, Mark R Thursz, Pinelopi Manousou
Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. International journal of molecular sciences 24 (4) (2023)
Nila Jambulingam, Roberta Forlano, Benjamin Preston, Benjamin Harvey Mullish, Greta Portone, Yama Baheer, Michael Yee, Robert D Goldin, Mark R Thursz, Pinelopi Manousou
Metabolic Profile Reflects Stages of Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. International journal of molecular sciences 24 (4) (2023)
Mei Ran Abellona U, Yi-Liang Eric Shen, Caroline Cartlidge, Alzhraa Alkhatib, Mark R Thursz, Imam Waked, Asmaa I Gomaa, Elaine Holmes, Rohini Sharma, Simon D Taylor-Robinson
Optimized Systematic Review Tool: Application to Candidate Biomarkers for the Diagnosis of Hepatocellular Carcinoma. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 31 (7) (2022)
Stephen Rahul Atkinson, Mahmoud Aly, Katharina Remih, Luke David Tyson, Nurdan Guldiken, Robert Goldin, Alberto Quaglia, Mark R Thursz, Pavel Strnad
Serum keratin 19 (CYFRA21-1) is a prognostic biomarker in severe alcoholic hepatitis. Liver international : official journal of the International Association for the Study of the Liver 42 (5) (2022)
Laura Martinez-Gili, Julie Anne Kathryn McDonald, Zhigang Liu, Dina H Kao, Jessica R Allegretti, Tanya Marie Monaghan, Grace F Barker, Jesus Miguens Blanco, Horace R T Williams, Elaine Holmes, Mark R Thursz, Julian R Marchesi, Benjamin Harvey Mullish
Understanding the mechanisms of efficacy of fecal microbiota transplant in treating recurrent Clostridioides difficile infection and beyond: the contribution of gut microbial-derived metabolites. Gut microbes 12 (1) (2021)
Roberta Forlano, Christopher Harlow, Benjamin Harvey Mullish, Mark R Thursz, Pinelopi Manousou, Michael Yee
Binge-eating disorder is associated with an unfavorable body mass composition in patients with non-alcoholic fatty liver disease. The International journal of eating disorders 54 (11) (2021)
Benjamin Harvey Mullish, Roberta Forlano, Robin Daniel Abeles, Mark R Thursz, Pinelopi Manousou
Letter: role of mean platelet volume levels in the prediction of major acute cardiovascular events in patients with non-alcoholic fatty liver disease-authors' reply. Alimentary pharmacology & therapeutics 50 (10) (2020)
Ashwin D Dhanda, Stephen R Atkinson, Nikhil Vergis, Doyo Enki, Andrew Fisher, Robert Clough, Matthew E Cramp, Mark R Thursz
Trace element deficiency is highly prevalent and associated with infection and mortality in patients with alcoholic hepatitis. Alimentary pharmacology & therapeutics 52 (3) (2020)
Benjamin Harvey Mullish, Roberta Forlano, Robin Daniel Abeles, Mark R Thursz, Pinelopi Manousou
Editorial: importance of an elevated mean platelet volume for prediction of major adverse cardiovascular events in non-alcoholic fatty liver disease - authors' reply. Alimentary pharmacology & therapeutics 49 (8) (2020)
Robin D Abeles, Benjamin Harvey Mullish, Roberta Forlano, Torben Kimhofer, Maciej Adler, Alexandros Tzallas, Nikolaos Giannakeas, Michael Yee, Jamil Mayet, Robert D Goldin, Mark R Thursz, Pinelopi Manousou
Derivation and validation of a cardiovascular risk score for prediction of major acute cardiovascular events in non-alcoholic fatty liver disease; the importance of an elevated mean platelet volume. Alimentary pharmacology & therapeutics 49 (8) (2019)
Kris Bennett, Doyo G Enki, Mark R Thursz, Matthew E Cramp, Ashwin D Dhanda
Systematic review with meta-analysis: high mortality in patients with non-severe alcoholic hepatitis. Alimentary pharmacology & therapeutics 50 (3) (2019)